Literature DB >> 32220219

Chorioallantoic Membrane Assay as Model for Angiogenesis in Tissue Engineering: Focus on Stem Cells.

Greet Merckx1, Hanna Tay2, Melissa Lo Monaco1,3, Marc van Zandvoort4, Ward De Spiegelaere2, Ivo Lambrichts1, Annelies Bronckaers1.   

Abstract

Tissue engineering aims to structurally and functionally regenerate damaged tissues, which requires the formation of new blood vessels that supply oxygen and nutrients by the process of angiogenesis. Stem cells are a promising tool in regenerative medicine due to their combined differentiation and paracrine angiogenic capacities. The study of their proangiogenic properties and associated potential for tissue regeneration requires complex in vivo models comprising all steps of the angiogenic process. The highly vascularized extraembryonic chorioallantoic membrane (CAM) of fertilized chicken eggs offers a simple, easy accessible, and cheap angiogenic screening tool compared to other animal models. Although the CAM assay was initially primarily performed for evaluation of tumor growth and metastasis, stem cell studies using this model are increasing. In this review, a detailed summary of angiogenic observations of different mesenchymal, cardiac, and endothelial stem cell types and derivatives in the CAM model is presented. Moreover, we focus on the variation in experimental setup, including the benefits and limitations of in ovo and ex ovo protocols, diverse biological and synthetic scaffolds, imaging techniques, and outcome measures of neovascularization. Finally, advantages and disadvantages of the CAM assay as a model for angiogenesis in tissue engineering in comparison with alternative in vivo animal models are described. Impact statement The chorioallantoic membrane (CAM) assay is an easy and cheap screening tool for the angiogenic properties of stem cells and their associated potential in the tissue engineering field. This review offers an overview of all published angiogenic studies of stem cells using this model, with emphasis on the variation in used experimental timeline, culture protocol (in ovo vs. ex ovo), stem cell type (derivatives), scaffolds, and outcome measures of vascularization. The purpose of this overview is to aid tissue engineering researchers to determine the ideal CAM experimental setup based on their specific study goals.

Entities:  

Keywords:  angiogenesis; chorioallantoic membrane assay; stem cells; tissue engineering

Year:  2020        PMID: 32220219     DOI: 10.1089/ten.TEB.2020.0048

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  9 in total

Review 1.  Experimental Models to Study Skin Wound Healing with a Focus on Angiogenesis.

Authors:  Eberhard Grambow; Heiko Sorg; Christian G G Sorg; Daniel Strüder
Journal:  Med Sci (Basel)       Date:  2021-08-25

2.  In Vivo Modulation of Angiogenesis and Immune Response on a Collagen Matrix via Extracorporeal Shockwaves.

Authors:  Diana Heimes; Nadine Wiesmann; Jonas Eckrich; Juergen Brieger; Stefan Mattyasovszky; Peter Proff; Manuel Weber; James Deschner; Bilal Al-Nawas; Peer W Kämmerer
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

3.  Characterization of Properties, In Vitro and In Vivo Evaluation of Calcium Phosphate/Amino Acid Cements for Treatment of Osteochondral Defects.

Authors:  Lubomir Medvecky; Maria Giretova; Radoslava Stulajterova; Jan Danko; Katarina Vdoviakova; Lenka Kresakova; Zdenek Zert; Eva Petrovova; Katarina Holovska; Maros Varga; Lenka Luptakova; Tibor Sopcak
Journal:  Materials (Basel)       Date:  2021-01-17       Impact factor: 3.623

4.  Cilostazol induces angiogenesis and regulates oxidative stress in a dose-dependent manner: A chorioallantoic membrane study.

Authors:  Mustafa Etli; Oğuz Karahan; Özgür Akkaya; Hasan Basri Savaş
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-10-20       Impact factor: 0.332

5.  Methotrexate and Cetuximab-Biological Impact on Non-Tumorigenic Models: In Vitro and In Ovo Assessments.

Authors:  Andreea M Kis; Ioana Macasoi; Corina Paul; Matilda Radulescu; Roxana Buzatu; Claudia G Watz; Adelina Cheveresan; Delia Berceanu; Iulia Pinzaru; Stefania Dinu; Aniko Manea; Marioara Poenaru; Claudia Borza; Cristina A Dehelean
Journal:  Medicina (Kaunas)       Date:  2022-01-22       Impact factor: 2.430

Review 6.  Cell-Seeded Biomaterial Scaffolds: The Urgent Need for Unanswered Accelerated Angiogenesis.

Authors:  Hanieh Shokrani; Amirhossein Shokrani; S Mohammad Sajadi; Farzad Seidi; Amin Hamed Mashhadzadeh; Navid Rabiee; Mohammad Reza Saeb; Tejraj Aminabhavi; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2022-03-12

7.  Dimethyl Sulfoxide: Morphological, Histological, and Molecular View on Developing Chicken Liver.

Authors:  Lenka Luptakova; Simona Dvorcakova; Zuzana Demcisakova; Lassaad Belbahri; Katarina Holovska; Eva Petrovova
Journal:  Toxics       Date:  2021-03-12

8.  3D-microtissue derived secretome as a cell-free approach for enhanced mineralization of scaffolds in the chorioallantoic membrane model.

Authors:  Lukas Otto; Petra Wolint; Annina Bopp; Anna Woloszyk; Anton S Becker; Andreas Boss; Roland Böni; Maurizio Calcagni; Pietro Giovanoli; Simon P Hoerstrup; Maximilian Y Emmert; Johanna Buschmann
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

9.  Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760-Benefit or Detriment in Essential Hypertension?

Authors:  Andrea Berenyiova; Iveta Bernatova; Anna Zemancikova; Magdalena Drobna; Martina Cebova; Samuel Golas; Peter Balis; Silvia Liskova; Zuzana Valaskova; Katarina Krskova; Stefan Zorad; Ezgi Dayar; Sona Cacanyiova
Journal:  Biomedicines       Date:  2021-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.